Your browser doesn't support javascript.
loading
Stent retriever AssIsted Lysis (SAIL) Technique with Tirofiban: A Potential Bailout Alternative to Angioplasty and Stenting.
Rodrigo-Gisbert, Marc; Hoferica, Matús; García-Tornel, Alvaro; Requena, Manuel; Rubiera, Marta; De Dios Lascuevas, Marta; Olivé-Gadea, Marta; Diana, Francesco; Rizzo, Federica; Muchada, Marian; Carmona, Tomás; Rodriguez-Villatoro, Noelia; Rodríguez-Luna, David; Juega, Jesus; Pagola, Jorge; Hernández, David; Molina, Carlos A; Tomasello, Alejandro; Cognard, Christophe; Ribo, Marc.
Affiliation
  • Rodrigo-Gisbert M; From the Stroke Unit, Hospital Universitari Vall d'Hebron, Departament de Medicina, Universitat Autònoma de Barcelona, Barcelona, Spain (MR-G, AGT, MRe, MRu, MO-G, FR, MM, NR-V, DR-V, JJ, JP, CM, MRi). Deparment of Diagnostic Neuroradiology, Hôpital Purpan, Centre Hospitalier Universitaire. Toulouse
  • Hoferica M; From the Stroke Unit, Hospital Universitari Vall d'Hebron, Departament de Medicina, Universitat Autònoma de Barcelona, Barcelona, Spain (MR-G, AGT, MRe, MRu, MO-G, FR, MM, NR-V, DR-V, JJ, JP, CM, MRi). Deparment of Diagnostic Neuroradiology, Hôpital Purpan, Centre Hospitalier Universitaire. Toulouse
  • García-Tornel A; From the Stroke Unit, Hospital Universitari Vall d'Hebron, Departament de Medicina, Universitat Autònoma de Barcelona, Barcelona, Spain (MR-G, AGT, MRe, MRu, MO-G, FR, MM, NR-V, DR-V, JJ, JP, CM, MRi). Deparment of Diagnostic Neuroradiology, Hôpital Purpan, Centre Hospitalier Universitaire. Toulouse
  • Requena M; From the Stroke Unit, Hospital Universitari Vall d'Hebron, Departament de Medicina, Universitat Autònoma de Barcelona, Barcelona, Spain (MR-G, AGT, MRe, MRu, MO-G, FR, MM, NR-V, DR-V, JJ, JP, CM, MRi). Deparment of Diagnostic Neuroradiology, Hôpital Purpan, Centre Hospitalier Universitaire. Toulouse
  • Rubiera M; From the Stroke Unit, Hospital Universitari Vall d'Hebron, Departament de Medicina, Universitat Autònoma de Barcelona, Barcelona, Spain (MR-G, AGT, MRe, MRu, MO-G, FR, MM, NR-V, DR-V, JJ, JP, CM, MRi). Deparment of Diagnostic Neuroradiology, Hôpital Purpan, Centre Hospitalier Universitaire. Toulouse
  • De Dios Lascuevas M; From the Stroke Unit, Hospital Universitari Vall d'Hebron, Departament de Medicina, Universitat Autònoma de Barcelona, Barcelona, Spain (MR-G, AGT, MRe, MRu, MO-G, FR, MM, NR-V, DR-V, JJ, JP, CM, MRi). Deparment of Diagnostic Neuroradiology, Hôpital Purpan, Centre Hospitalier Universitaire. Toulouse
  • Olivé-Gadea M; From the Stroke Unit, Hospital Universitari Vall d'Hebron, Departament de Medicina, Universitat Autònoma de Barcelona, Barcelona, Spain (MR-G, AGT, MRe, MRu, MO-G, FR, MM, NR-V, DR-V, JJ, JP, CM, MRi). Deparment of Diagnostic Neuroradiology, Hôpital Purpan, Centre Hospitalier Universitaire. Toulouse
  • Diana F; From the Stroke Unit, Hospital Universitari Vall d'Hebron, Departament de Medicina, Universitat Autònoma de Barcelona, Barcelona, Spain (MR-G, AGT, MRe, MRu, MO-G, FR, MM, NR-V, DR-V, JJ, JP, CM, MRi). Deparment of Diagnostic Neuroradiology, Hôpital Purpan, Centre Hospitalier Universitaire. Toulouse
  • Rizzo F; From the Stroke Unit, Hospital Universitari Vall d'Hebron, Departament de Medicina, Universitat Autònoma de Barcelona, Barcelona, Spain (MR-G, AGT, MRe, MRu, MO-G, FR, MM, NR-V, DR-V, JJ, JP, CM, MRi). Deparment of Diagnostic Neuroradiology, Hôpital Purpan, Centre Hospitalier Universitaire. Toulouse
  • Muchada M; From the Stroke Unit, Hospital Universitari Vall d'Hebron, Departament de Medicina, Universitat Autònoma de Barcelona, Barcelona, Spain (MR-G, AGT, MRe, MRu, MO-G, FR, MM, NR-V, DR-V, JJ, JP, CM, MRi). Deparment of Diagnostic Neuroradiology, Hôpital Purpan, Centre Hospitalier Universitaire. Toulouse
  • Carmona T; From the Stroke Unit, Hospital Universitari Vall d'Hebron, Departament de Medicina, Universitat Autònoma de Barcelona, Barcelona, Spain (MR-G, AGT, MRe, MRu, MO-G, FR, MM, NR-V, DR-V, JJ, JP, CM, MRi). Deparment of Diagnostic Neuroradiology, Hôpital Purpan, Centre Hospitalier Universitaire. Toulouse
  • Rodriguez-Villatoro N; From the Stroke Unit, Hospital Universitari Vall d'Hebron, Departament de Medicina, Universitat Autònoma de Barcelona, Barcelona, Spain (MR-G, AGT, MRe, MRu, MO-G, FR, MM, NR-V, DR-V, JJ, JP, CM, MRi). Deparment of Diagnostic Neuroradiology, Hôpital Purpan, Centre Hospitalier Universitaire. Toulouse
  • Rodríguez-Luna D; From the Stroke Unit, Hospital Universitari Vall d'Hebron, Departament de Medicina, Universitat Autònoma de Barcelona, Barcelona, Spain (MR-G, AGT, MRe, MRu, MO-G, FR, MM, NR-V, DR-V, JJ, JP, CM, MRi). Deparment of Diagnostic Neuroradiology, Hôpital Purpan, Centre Hospitalier Universitaire. Toulouse
  • Juega J; From the Stroke Unit, Hospital Universitari Vall d'Hebron, Departament de Medicina, Universitat Autònoma de Barcelona, Barcelona, Spain (MR-G, AGT, MRe, MRu, MO-G, FR, MM, NR-V, DR-V, JJ, JP, CM, MRi). Deparment of Diagnostic Neuroradiology, Hôpital Purpan, Centre Hospitalier Universitaire. Toulouse
  • Pagola J; From the Stroke Unit, Hospital Universitari Vall d'Hebron, Departament de Medicina, Universitat Autònoma de Barcelona, Barcelona, Spain (MR-G, AGT, MRe, MRu, MO-G, FR, MM, NR-V, DR-V, JJ, JP, CM, MRi). Deparment of Diagnostic Neuroradiology, Hôpital Purpan, Centre Hospitalier Universitaire. Toulouse
  • Hernández D; From the Stroke Unit, Hospital Universitari Vall d'Hebron, Departament de Medicina, Universitat Autònoma de Barcelona, Barcelona, Spain (MR-G, AGT, MRe, MRu, MO-G, FR, MM, NR-V, DR-V, JJ, JP, CM, MRi). Deparment of Diagnostic Neuroradiology, Hôpital Purpan, Centre Hospitalier Universitaire. Toulouse
  • Molina CA; From the Stroke Unit, Hospital Universitari Vall d'Hebron, Departament de Medicina, Universitat Autònoma de Barcelona, Barcelona, Spain (MR-G, AGT, MRe, MRu, MO-G, FR, MM, NR-V, DR-V, JJ, JP, CM, MRi). Deparment of Diagnostic Neuroradiology, Hôpital Purpan, Centre Hospitalier Universitaire. Toulouse
  • Tomasello A; From the Stroke Unit, Hospital Universitari Vall d'Hebron, Departament de Medicina, Universitat Autònoma de Barcelona, Barcelona, Spain (MR-G, AGT, MRe, MRu, MO-G, FR, MM, NR-V, DR-V, JJ, JP, CM, MRi). Deparment of Diagnostic Neuroradiology, Hôpital Purpan, Centre Hospitalier Universitaire. Toulouse
  • Cognard C; From the Stroke Unit, Hospital Universitari Vall d'Hebron, Departament de Medicina, Universitat Autònoma de Barcelona, Barcelona, Spain (MR-G, AGT, MRe, MRu, MO-G, FR, MM, NR-V, DR-V, JJ, JP, CM, MRi). Deparment of Diagnostic Neuroradiology, Hôpital Purpan, Centre Hospitalier Universitaire. Toulouse
  • Ribo M; From the Stroke Unit, Hospital Universitari Vall d'Hebron, Departament de Medicina, Universitat Autònoma de Barcelona, Barcelona, Spain (MR-G, AGT, MRe, MRu, MO-G, FR, MM, NR-V, DR-V, JJ, JP, CM, MRi). Deparment of Diagnostic Neuroradiology, Hôpital Purpan, Centre Hospitalier Universitaire. Toulouse
Article de En | MEDLINE | ID: mdl-38849135
ABSTRACT
BACKGROUND AND

PURPOSE:

Angioplasty and stenting (A&S) have been described as bailout technique in individuals with failed thrombectomy. We aim to investigate Stent retriever AssIsted Lysis (SAIL) with tirofiban prior to A&S. MATERIALS AND

METHODS:

Patients from 2 comprehensive stroke centers were reviewed (2020-2023). We included patients with failed thrombectomy and/or underlying intracranial stenosis who received SAIL with tirofiban prior to intended A&S.SAIL consisted in deploying a SR through the occluding lesion to create a by-pass channel and infuse 10ml of tirofiban over 10 minutes either intraarterially (IA) or intravenously (IV). The SR was re-sheathed before retrieval. Primary endpoints were successful reperfusion (eTICI 2b-3) and sICH. Additional endpoints included 90-day mRS 0-2 and mortality.

RESULTS:

After a median of 3 (IQR 2-4) passes, 44 patients received the SAIL bridging protocol with tirofiban and later they were considered potential candidates for A&S bailout (43.2% IA-SAIL). Post-SAIL successful reperfusion was obtained in 79.5%. A significant residual stenosis (>50%) after successful SAIL was observed in 45.7%.No significant differences were detected according to post-SAIL successful reperfusion (IA-SAIL 80.0% vs IV-SAIL 78.9%; p=0.932), post-SAIL significant stenosis (33.3% vs 55.0%; p=0.203), early symptomatic reocclusion (0% vs 8.0%; p=0.207), or sICH (5.3% vs 8.0%; p=0.721). Rescue A&S was finally performed in 15 (34.1%) patients (IA-SAIL 21.0% vs IV-SAIL 44%; p=0.112).At 90 days, mRS 0-2 (IA-SAIL 50.0% vs IV-SAIL 43.5%; p=0.086) and mortality (26.3% vs 12.0%; p=0.223) were also similar.

CONCLUSIONS:

In stroke patients in which A&S bailout is considered, SAIL with tirofiban, either intraarterial or intravenous, seems to safely induce sustained recanalization, offering a potential alternative to definitive A&S. ABBREVIATIONS A&S = Angioplasty and stenting, ICAD = Intracranial Atherosclerotic Disease, ICAS-LVO = Intracranial atherosclerosis related large vessel occlusion, EVT = Endovascular Treatment, LVO = Large Vessel Occlusion; MT = Mechanical Thrombectomy; SR = SR Stent Retriever; SAIL = Stent retriever AssIsted Lysis, sICH = Symptomatic Intracranial Hemorrhage.

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Langue: En Journal: AJNR Am J Neuroradiol Année: 2024 Type de document: Article

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Langue: En Journal: AJNR Am J Neuroradiol Année: 2024 Type de document: Article